We are live on ! Find out more
NSPRW

InspireMD, Inc. Warrants

Delisted

NSPRW was delisted on the 7th of July, 2021.

0 hedge funds and large institutions have $0 invested in InspireMD, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 30 (-3)

100% less capital invested

Capital invested by funds: $12K → $0 (-$12K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
Holders Change
-3
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
HF
1
HRT Financial
New York
-$4K -19,759 Closed
VF
2
Virtu Financial
New York
-$4K -19,402 Closed
UBS Group
3
UBS Group
Switzerland
-$4K -19,296 Closed

NSPRW Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q3 2021, worth a combined $0 — down 100% from $12K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NSPRW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was HRT Financial, exiting entirely with an estimated $4K sold.

  • 0 institutional investors held InspireMD, Inc. Warrants (NSPRW) as of Q3 2021, down from 3 in Q2 2021.
  • Funds reported $0 of InspireMD, Inc. Warrants stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Warrants positions in Q3 2021 and 3 closed out, a net change of -3 holders.
  • The largest InspireMD, Inc. Warrants seller in Q3 2021 was HRT Financial, an estimated $4K sold.

Based on aggregated 13F filings for Q3 2021.